Globe Newswire
Record First Quarter Net Revenue of $147.9 million, up 24.1% versus Prior Year PeriodRaises Fiscal Year 2024 OutlookAnnounces Plans for New State-of-the-Art Egg Washing and Packing Facility
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its first quarter ended March 31, 2024.
Financial highlights for the first... (continue reading...)
BEIJING, May 09, 2024 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (NASDAQ: KC and HKEX: 3896) (“Kingsoft Cloud” or the “Company”), a leading independent cloud service provider in China, today announced that it will release its unaudited financial results for the first quarter 2024 ended March 31, 2024 before the open of U.S. markets on Wednesday, May 22, 2024.
Kingsoft Cloud’s management will host an earnings conference call on Wednesday May... (continue reading...)
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Boussard & Gavaudan Investment Management LLP Boussard & Gavaudan Gestion SAS acting on behalf of various funds(b) Owner or controller of interests and short positions disclosed, if different... (continue reading...)PDUFA Target Action Date for Ensifentrine of June 26, 2024
Finalizing commercial launch preparations
Strong balance sheet supports commercialization and pipeline expansion
Conference call today at 9:00 a.m. EDT / 2:00 p.m. BST
LONDON and RALEIGH, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory diseases, announces its financial results for the... (continue reading...)
LAUSANNE, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 1:35 p.m. ET.
A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics’ website ir.adctherapeutics.com. A replay of... (continue reading...)
More Globe Newswire
View Older Stories-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - Tyman plc
-
Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call
-
Nevada Copper Files Financial Statements and MD&A for the Quarter Ended March 31, 2024
-
Xometry Reports First Quarter 2024 Results
-
Nevada Copper Files Financial Statements and MD&A for the Quarter Ended March 31, 2024
-
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
-
Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2024 Results
-
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Tower Semiconductor Reports 2024 First Quarter Financial Results
-
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
-
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
-
Treasury Metals and Blackwolf Announce Upsize to Concurrent Financing
-
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Optinose Announces $55 Million Registered Direct Offering
-
BioXcel Therapeutics Reports First Quarter 2024 Financial Results
-
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
-
Cerence Announces Second Quarter Fiscal Year 2024 Results
-
Lantronix to Participate in the 19th Annual Needham Technology, Media, & Consumer Investor Conference on May 14, 2024
-
BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
-
The Tile Shop Reports First Quarter 2024 Results
-
Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update
-
Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
-
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
-
BigCommerce Announces First Quarter 2024 Financial Results
-
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
-
Lifetime Brands, Inc. Reports First Quarter 2024 Financial Results
-
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
-
Royalty Pharma Reports First Quarter 2024 Results
-
Advantage Solutions Reports First Quarter Results with New Reporting Segments and Reaffirms its 2024 Outlook
-
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
PhotonPay and Discover® Global Network Connect to Launch PhotonPay Commercial Card
-
Tecnoglass Reports First Quarter 2024 Results
-
Aduro Clean Technologies Selected to Present at Chemelot Circular Hub Event in the Netherlands
-
Sterling Reports First Quarter 2024 Results
-
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
-
Dragonfly Energy Announces Breakthrough in Lithium Battery Production: Eliminating Harmful “Forever Chemicals”
-
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
-
Plug Announces First Quarter 2024 Financial Results
-
Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
-
Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline
-
LanzaTech Announces First Quarter 2024 Financial Results and Reiterates Full Year 2024 Outlook
-
Applied Therapeutics Reports First Quarter 2024 Financial Results
-
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
-
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month
-
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
-
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
-
Arqit warns CISOs why they must act now to secure their data ready for the post-quantum world